期刊文献+

EGFP基因修饰大鼠胚胎中脑神经干细胞的建立 被引量:1

Establishment of EGFP gene modified embryonic midbrain-derived neural stem cells in rats
下载PDF
导出
摘要 目的建立增强型绿色荧光蛋白(EGFP)基因修饰大鼠胚胎中脑神经干细胞。方法以质粒pEGFPN1转染培养第三代的大鼠胚胎中脑神经干细胞(mNSCs),经G418筛选后,分别进行nestin免疫细胞化学鉴定和诱导分化后β-Ⅲ-tubulin、GFAP、CNPase免疫细胞化学鉴定。结果 EGFP在基因转染12 h后开始表达,24 h后明显增加,48 h达到高峰,经G418筛选1月后有阳性克隆形成,EGFP基因修饰不影响大鼠胚胎mNSCs的增殖与分化。结论成功建立EGFP基因修饰大鼠胚胎mNSCs,为进一步开展帕金森病的细胞移植治疗研究奠定基础。 Objective To establish enhanced green fluorescent protein (EGFP) gene modified midbrain-derived neural stem ceils (mNSCs). Methods The E14 rat embryonic mNSCs were isolated and cultured. The ceils of the third passage were transfected with plasmid pEGFPN1 using FuGENE HD transfection reagent. The expressions of EGFP were observed under fluorescence microscope. 48 hours after transfection, the transfected cells were screened with medium containing G418. The positive clones were selected, proliferated and then identified with immunocytochemistery for nestin. At the same time, the cells were inducted to differentiation. The distinctive marker for neuron (ρ-Ⅲ-tubulin), dopaminergic neuron ( TH), astrocyte (GFAP) and oligodendrocyte (CNPase) were employed to detect the phenol type of differentiated cells. Results The expression of EGFP was initially found 12 hours after transfection, increased remarkable 24 hours after transfection and reached a summit at 48 hours. One month after screened with medium containing G418, the positive clones were formed. The immunocytochemistery showed the cells were nestin positive, after differentiation the cells expressed ρ-Ⅲ-tubulin, TH, GFAP and CNPase. Conclusions The EGFP gene modified embryonic mNSCs in rats were successfully established, which will provide the foundation for the further research about cell therapy of Parkinson' s disease.
出处 《临床神经外科杂志》 CAS 2010年第3期116-118,共3页 Journal of Clinical Neurosurgery
基金 云南省教育厅科学研究基金(09Y0153) 昆明医学院第一附属医院博士启动基金
关键词 增强型绿色荧光蛋白基因 中脑神经干细胞 基因转染 enhanced green fluorescent protein gene midbrain-derived neural stem cells transfection
  • 相关文献

参考文献6

  • 1Martino G,Pluchino S.The therapeutic potential of neural stem cells[J].Nat Rev Neurosci,2006,7:395. 被引量:1
  • 2Storch A,Sabolek M,Milosevic J,et al.Midbrain-derived neural stem cells:from basic science to therapeutic approaches[J].Cell Tissue Ras,2004,318:15. 被引量:1
  • 3Ward TH,Lippincott-Schwartz J.The uses of green fluorescent protein in mammalian cells[J].Methods Biochem Anal,2006,47:305. 被引量:1
  • 4Xingli Deng,Ruen Liu,Zhongtang Feng,Jing Guo,Wu Wang,Deqiang Lei,Hongyan Li,Zhihua Chen.In vitro culture and differentiation of rat embryonic midbrain-derived neural stem cells[J].Neural Regeneration Research,2008,3(11):1241-1244. 被引量:19
  • 5Chinswangwatanakul W,Lewis JL,Manning M,et al.Use of G418 resistance to select cells retrovirally transduced with the Neo(R)gene[J].Exp Hematol,1998,26:185. 被引量:1
  • 6Bazan E,Alonso FJ,Redondo C,et al.In vitro and in vivo characterization of neural stem cells[J].Histol Histopathol,2004,19:1261. 被引量:1

二级参考文献16

  • 1[1]Lew M.Overview of Parkinson's disease.Pharmacotherapy.2007 Dec;27(12 Pt 2):155S-60S 被引量:1
  • 2[2]Tabbal S,Fahn S,Frucht S.Fetal tissue transplantation[correction of transplanation] in Parkinson's disease.Curr Opin Neurol 1998; 11 (4):341-9 被引量:1
  • 3[3]Freed CR,Greene PE,Breeze RE,et al.Transplantation of embryonic dopamine neurons for severe Parkinson's disease.N Engl J Med 2001;344(10):710-9 被引量:1
  • 4[4]Takahashi J.Stem cell therapy for Parkinson's disease.Expert Rev Neurother 2007;7(6):667-75 被引量:1
  • 5[5]Trzaska KA,Rameshwar P.Current advances in the treatment of Parkinson's disease with stem cells.Curr Neurovasc Res 2007 ;4(2):99-109 被引量:1
  • 6[6]Kornblum HI.Introduction to neural stem cells.Stroke 2007; 38(2 Suppl):810-6 被引量:1
  • 7[7]Kim HT,Kim IS,Lee IS,et al.Human neurospheres derived from the fetal central nervous system are regionally and temporally specified but are not committed.Exp Neurol 2006;199(1):222-35 被引量:1
  • 8[8]Storch A,Sabolek M,Milosevic J,et al.Midbrain-derived neural stem cells:from basic science to therapeutic approaches.Cell Tissue Res 2004;318(1):15-22 被引量:1
  • 9[9]The Ministry of Science and Technology of the People's Republic of China.Guidance Suggestion of the Care and Use of Laboratory Animals.2006-09-30. 被引量:1
  • 10[10]Jensen JB,Parmar M.Strengths and limitations of the neurosphere culture system.Mol Neurobiol 2006;34(3):153-61 被引量:1

共引文献18

同被引文献8

  • 1Adami R, Scesa G, Bottai D. Stem cell transplanlation in netn'o- logical diseases: improving effectiveness in animal models [ J ]. Front Cell Dev Biol, 2014, 2( 1 ) : 17. 被引量:1
  • 2ltoriguehi S, Takahashi J, Kishi Y, el al. Neural preeuor ceils derived from human embl.n, onie brain retain regional specificity [J]. J Neurosci Res, 2004, 75(6) : 817 -824. 被引量:1
  • 3Deng X, I,iang Y, Lu H, el al. Co - transplantation ot" GDNF - overexpressing neural stem cells and fetal dopaininergie neurons mitigates motor symptoms in a rat model of Parkinson's disease [J]. PLoSOne, 2013, 12(8): e80880. 被引量:1
  • 4Czyzyk- Krzeska MF, Fumari BA, l,awson EE, el al. Hypoxia increases rate of transcription and stability of tyrosine hydroxylase mRNA in pheochromocytoma ( PCI2 ) cells [ J ]. J Biol Chem, 1994, 269( 1 ) : 760 -764. 被引量:1
  • 5Song T, Chen G, Wang Y, et al. Chemically defined sequential cuhure media for TH + cell derivation from human embryonic stem cells[J]. Mol Hum Reprod, 2008, 14(11 ) : 619 -625. 被引量:1
  • 6丁继固.中脑神经干细胞转基因治疗帕金森病:可能与可行?[J].中国组织工程研究与临床康复,2010,14(10):1855-1860. 被引量:7
  • 7刘波,黄涛,沈勇,蒋宏国,杨智勇,邓兴力.pCDNA3.1-Nurr1真核表达载体的构建及其表达[J].广东医学,2014,35(22):3471-3473. 被引量:1
  • 8魏翔,刘晓莉.帕金森病大鼠模型运动行为测评方法的研究进展[J].中国实验动物学报,2015,23(2):209-215. 被引量:11

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部